Company:  INSPIREMD, INC. (NSPR)
Form Type:  10-Q
Filing Date:  5/7/2014 
CIK:  0001433607 
Address:  321 COLUMBUS AVENUE 
City, State, Zip:  BOSTON, Massachusetts 02116 
Telephone:  (857) 453-6553 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$0.20  
Change: 
-0.002 (-1.00%)  
Trade Time: 
Sep 02  
Market Cap: 
$15.42M
Trade NSPR now with 

Description of Business
We are a medical device company focusing on the development and commercialization of our proprietary MicroNet stent platform technology for the treatment of complex coronary and vascular disease. A stent is an expandable "scaffold-like" device, usually constructed of a metallic material, that is inserted into an artery to expand the inside passage and improve blood flow. Our MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Our initial MGuard coronary products (MGuard and MGuard Prime Embolic Protection Stent (EPS)) are marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery).
Register and access this filing in:     
  FORM 10-Q
    PART I - FINANCIAL INFORMATION
      Item 1. Financial Statements
        BALANCE SHEET
        BALANCE SHEET
        CASH FLOW
        NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
          NOTE 12 - SUBSEQUENT EVENTS:
      Item 2. Management's Discussion and Analysis of Financial ...
      Item 4. Controls and Procedures
    PART II - OTHER INFORMATION
      Item 1. Legal Proceedings
      Item 1A. Risk Factors
      Item 2. Unregistered Sales of Equity Securities and Use of ...
      Item 5. Other Information.
      Item 6. Exhibits
    SIGNATURES
    EXHIBIT INDEX
  EXHIBIT 10.2
  EXHIBIT 10.3
  EXHIBIT 31.1
    CERTIFICATION OF CHIEF EXECUTIVE OFFICER
  EXHIBIT 31.2
    CERTIFICATION OF CHIEF FINANCIAL OFFICER
  EXHIBIT 32.1
    CERTIFICATION OF CHIEF EXECUTIVE OFFICER
  EXHIBIT 32.2
    CERTIFICATION OF CHIEF FINANCIAL OFFICER